BNP/CALL/MERCK & CO./110/0.1/19.12.25 | Market Closed - Börse Stuttgart 08:12:51 05/07/2024 BST | ||
| 2.35 EUR | -1.26% |
|
| Current month | -14.86% | ||
| 1 month | -9.62% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
MERCK & CO., INC.
Latest news about MERCK & CO., INC.
More news
| Date | Price | Change |
|---|---|---|
| 05/07/24 | 2.35 | -1.26% |
| 04/07/24 | 2.38 | -8.11% |
| 03/07/24 | 2.59 | +2.78% |
| 02/07/24 | 2.52 | +9.57% |
| 01/07/24 | 2.3 | -16.67% |
Delayed Quote Börse Stuttgart
Last update July 05, 2024 at 08:12 am
More quotesStatic data
| Product type | Plain-Vanilla-Warrants |
|---|---|
| Buy / Sell | CALL |
| Underlying | MERCK & CO., INC. |
| Issuer | 
BNP Paribas
|
| WKN | PC1LLL |
| ISIN | DE000PC1LLL7 |
| Date issued | 11/12/2023 |
| Strike | 110 $ |
| Maturity | 19/12/2025 (530 Days) |
| Parity | 10 : 1 |
| Emission price | 1.02 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 3 € |
|---|---|
| Lowest since issue | 1.09 € |
| Spread | 0.01 € |
| Spread % | 0.41% |
Company Profile
Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows:
- sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.;
- sale of vaccines (18%);
- sale of animal health products (9.4%);
- other (2.9%).
Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
Consensus: Merck & Co., Inc.
Sell
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
126.4
USD
Average target price
142.7
USD
Spread / Average Target
+12.84%
- Stock Market
- Warrants
- Warrant
